Joint ACTRIMS-ECTRIMS Meeting

Joint ACTRIMS-ECTRIMS Meeting

Source:

Healio Interviews

Disclosures: Cohen reports no relevant financial disclosures.
September 11, 2020
1 min watch
Save

VIDEO: COVID-19 ‘hasn’t stopped’ MS care, research

Source:

Healio Interviews

Disclosures: Cohen reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video from MSVirtual2020, Jeffrey Cohen, MD, professor of medicine (neurology) at Cleveland Clinic Lerner College of Medicine and ACTRIMS president, provides an overview of what to expect from the meeting. The 8th Joint ACTRIMS-ECTRIMS Meeting is being held from Sept. 11-13, 2020, in a virtual format because of the COVID-19 pandemic.

“One aspect of the story is the meeting itself,” Cohen told Healio Neurology. “Most of us spend a lot of time on Zoom conferences now, but I don’t think many of us have attended a large scientific meeting virtually.”

The meeting features four tracks, according to Cohen: clinical, pathogenesis, translational and environmental/genetic factors. He classified the themes of the meeting into three categories, including the treatment of MS and related diseases; the causes of MS and the processes that result in neurologic damage; and the tests used to diagnose and monitor the disease.

“The field hasn’t stopped” because of the pandemic, Cohen said. “We’re still making progress. We’re refining how we use available treatments, we’re still developing new treatments and we’re developing treatments to address novel aspects of the disease.”

MSVirtual2020 will feature an encore session on Saturday, Sept. 26, 2020, with late-breaking abstracts and a COVID-19 presentation.